RxDoctor Payments Data

Sarah Mahoney, PA

Physician Assistant · Bozeman, MTNPI 1952761264

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 75 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by AbbVie at 34.8% of the total. Among physician assistant clinicians in MT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,466in general payments, 2019–2025

Across 75 payments — averaging $19.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$511
  • Lilly USA, LLC$186
  • E.r. Squibb & Sons, L.L.C.$130
  • AstraZeneca$97
  • Novo Nordisk$89
  • Inspire Medical Systems, Inc.$85
  • plus $368 from 11 others

What the payments were for

  • Food & beverage$1,466100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,466 in reported general payments places this provider in the 90th percentile of 626 physician assistant providers in Montana.

See all physician assistant providers in Montana

Medicare billing

Part B allowed, 2024
$27,163
Medicare patients
94
Services billed
822

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban23$27,537
Breo ElliptaFluticasone/Vilanterol12$4,481
Losartan Potassium61$762
Levothyroxine Sodium56$601
Atorvastatin Calcium71$556
Venlafaxine Hcl ErVenlafaxine Hcl26$467
Pravastatin Sodium11$351
Omeprazole31$304
Amlodipine Besylate44$299
Duloxetine Hcl11$294
Lisinopril32$258
Sertraline Hcl17$185
Escitalopram Oxalate18$170
Eszopiclone16$133
Metoprolol Succinate20$127

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$67$27,53723 claims
GSKBreo Ellipta$29$4,48112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 626 physician assistant providers in Montana.

Other physician assistant in Bozeman

See the full list for Montana

Where these figures come from

Is this you, or does something look wrong? →